Dr. Larry Leeman: Breaking Ground with MDMA-Assisted Therapy for New Mothers

Welcome back Dr. Larry Leeman! As you may remember from his last episode, Dr. Leeman and his colleagues launched a first-of-its-kind pilot study to explore whether a regimen of trauma-focused therapy coupled with doses of MDMA – popularly known as ecstasy or molly – can help new mothers permanently overcome their drug dependency. In this episode, we dive into the latest developments of this groundbreaking study. The study involves a 14-week therapy program, including three MDMA sessions, specifically targeting women who have had a baby within the last 3-9 months, have PTSD, and whose opioid use is stabilized via medication. This research is revolutionary as it marks the first time the FDA has included members with substance use disorder in such a study. We'll break down how MDMA works, why it is effective for this population, and what this means for the future of addiction treatment. Tune in to learn more about this pioneering approach and its potential to change lives! STUDY INFO: The uAspire study of Major Depression at the University of New Mexico. Interested potential participants can contact the study team at  [email protected] or leave a text or message at (505) 600-1448 The RECONNECT study of Postpartum Depression. This is a randomized study for people with depression diagnosed from 14 weeks of pregnancy until 4 weeks postpartum and are with 12 months of childbirth. They cannot be breastfeeding. Interested potential participants can contact the study team at [email protected] or leave a text or message at (505) 600-1448 DONATE TO THE STUDY: https://impactunm.unmfund.org/s/1959/22/interior.aspx?sid=1959&gid=2&pgid=707&_ga=2.117355332.313416249.1688255792-804041491.1664997619 We now have a link to the video from  Dr. Charles Raison's May 7th 2024 presentation on Psilocybin for Depression: Mechanisms and Challenges : https://www.youtube.com/watch?v=-5bsbMbMr-s&ab_channel=UNMFCM